Rankings
▼
Calendar
APGE (Apogee Therapeutics, Inc.) Stock Financials & Earnings | Market Cap Arena
APGE
Apogee Therapeutics, Inc.
Mkt Cap
$4B
Healthcare
·
Biotechnology
·
🇺🇸 United States
·
NASDAQ
Revenue (TTM)
$0
Net Income (TTM)
$0
EPS (TTM)
-$4.22
Free Cash Flow (TTM)
-$233M
Gross Margin
—
Op. Margin
—
Net Margin
—
FCF Margin
—
P/S Ratio (TTM)
—
P/E Ratio (TTM)
—
YoY Rev Growth
—
Employees
—
Earnings Reports
▶
Q4 2025
NEW
Browse All Reports
Quarterly
FY
Revenue & Profitability
Revenue
Gross Profit
Operating Income
Quarter
Revenue
Gross Profit
Op. Income
Q1 23
$0
$0
-$13M
Q2 23
$0
$0
-$19M
Q3 23
$0
$0
-$24M
Q4 23
$0
$0
-$37M
Q1 24
$0
$0
-$38M
Q2 24
$0
$0
-$44M
Q3 24
$0
$0
-$59M
Q4 24
$0
$0
-$76M
Q1 25
$0
$0
-$63M
Q2 25
$0
$0
-$73M
Q3 25
$0
-$400K
-$71M
Q4 25
$0
$400K
-$78M
marketcaparena.com
Operating Cash Flow
Operating Cash Flow
Free Cash Flow
Quarter
Operating CF
Free CF
Q1 23
-$11M
-$11M
Q2 23
-$15M
-$15M
Q3 23
-$20M
-$20M
Q4 23
-$30M
-$30M
Q1 24
-$32M
-$32M
Q2 24
-$29M
-$29M
Q3 24
-$43M
-$43M
Q4 24
-$68M
-$68M
Q1 25
-$48M
-$53M
Q2 25
-$62M
-$63M
Q3 25
-$54M
-$54M
Q4 25
-$63M
-$63M
marketcaparena.com
Capital Expenditures
CapEx
Quarter
CapEx
Q1 23
$0
Q2 23
$0
Q3 23
$0
Q4 23
$167K
Q1 24
$351K
Q2 24
$51K
Q3 24
$751K
Q4 24
$1K
Q1 25
$4M
Q2 25
$768K
Q3 25
$0
Q4 25
$62K
marketcaparena.com
OpEx vs Revenue Growth (YoY)
Revenue Growth
OpEx Growth
Quarter
Revenue Growth
OpEx Growth
Q1 23
—
+194.0%
Q2 23
—
+939.9%
Q3 23
—
+131.3%
Q4 23
—
+163.5%
Q1 24
—
+201.6%
Q2 24
—
+133.6%
Q3 24
—
+141.5%
Q4 24
—
+104.2%
Q1 25
—
+65.3%
Q2 25
—
+65.8%
Q3 25
—
+21.5%
Q4 25
—
+2.9%
marketcaparena.com
Stock-Based Compensation
SBC ($)
% of Revenue
Quarter
SBC ($)
% of Revenue
Q1 23
$1M
—
Q2 23
$1M
—
Q3 23
$2M
—
Q4 23
$2M
—
Q1 24
$4M
—
Q2 24
$6M
—
Q3 24
$6M
—
Q4 24
$8M
—
Q1 25
$11M
—
Q2 25
$11M
—
Q3 25
$12M
—
Q4 25
$12M
—
marketcaparena.com
OpEx Breakdown
R&D
G&A
Quarter
R&D
G&A
Q1 23
$8M
$4M
Q2 23
$14M
$5M
Q3 23
$17M
$7M
Q4 23
$29M
$8M
Q1 24
$29M
$9M
Q2 24
$33M
$11M
Q3 24
$46M
$13M
Q4 24
$60M
$16M
Q1 25
$46M
$17M
Q2 25
$56M
$17M
Q3 25
$54M
$17M
Q4 25
$58M
$20M
marketcaparena.com
War Chest
Cash & Equivalents
Short-Term Investments
Quarter
Cash
Short-term Investments
Total
Q1 23
$141M
$0
$141M
Q2 23
$125M
$0
$125M
Q3 23
$188M
$235M
$423M
Q4 23
$118M
$277M
$395M
Q1 24
$485M
$331M
$816M
Q2 24
$307M
$369M
$676M
Q3 24
$119M
$407M
$526M
Q4 24
$142M
$379M
$521M
Q1 25
$107M
$406M
$513M
Q2 25
$124M
$381M
$505M
Q3 25
$108M
$419M
$527M
Q4 25
$132M
$599M
$730M
marketcaparena.com
Shares Outstanding
Shares Outstanding
Quarter
Shares (Diluted)
QoQ Change
Q1 23
51M
+0.0%
Q2 23
51M
+0.0%
Q3 23
51M
+0.0%
Q4 23
51M
-0.0%
Q1 24
50M
-0.9%
Q2 24
57M
+12.6%
Q3 24
57M
+0.5%
Q4 24
55M
-2.8%
Q1 25
58M
+5.4%
Q2 25
58M
+0.4%
Q3 25
59M
+0.6%
Q4 25
61M
+3.3%
marketcaparena.com
Revenue Per Employee
Revenue / Employee
Year
Revenue/Employee
Employees
FY 22
—
—
FY 23
$0
91
FY 24
$0
150K
FY 25
$0
150K
marketcaparena.com